Cancer incidence by age visualisation
For many different cancers, this data visualisation provides cancer incidence data by age for a wide range of age groups. Help with terms, and information about the data, is available by placing the mouse pointer over the icons found near the top of the page.
Note: Some cancer incidence projections have changed more considerably from the 2024 report estimates
The AIHW projects cancer incidence, mortality and prevalence to estimate counts and rates for the years where complete national data are not yet available, based on trends for the previous 10 years (for example, 2012–2021). Each year, AIHW updates the projections and includes a new year of data. In this release, actual data from 2020 and 2021 (during the COVID-19 pandemic) have been included in the projections for some cancers for the first time. Because of this, changes to estimates for previous years are greater than usual for some cancers, including (but not limited to) breast cancer, melanoma of the skin, colorectal cancer and colon cancer. For further information, please see the Methods section.
Cancer incidence by various age groups data visualisation
This cancer incidence visualisation contains two figures. The visualisation presents statistics for the selected cancer and provides information by sex.
Figure 1 is a line and bar graph that contains information on the number of cancer cases diagnosed (bar chart) and the rate of diagnosis (line graph) from 1982 to the most recent year available for reporting at the time of release. For a selected age group (other than all ages), the line graph represents the age-specific rate. The crude rate or age-standardised rate can be selected for all ages. Age-group reporting can be selected by 5-, 10-, 15-, 20-, 25-, 30-, 35-, 40-, 45- and 50-year age groups.
Figure 2 is a line graph that contains mean or median age (in years) at cancer diagnosis from 1982 to most recent year available for reporting at the time of release.
The visualisation includes information about many different cancers and the statistics within this visualisation are available in Excel format within the Data section of this report.
Cancer incidence by age data are available as supplementary tables.
AIHW (Australian Institute of Health and Welfare) 2019. BreastScreen Australia monitoring report 2018. Cancer series no.127. Cat no. CAN 128. Canberra: AIHW
Al-Marhoon M, Osman A, Kamal M and Shokier A 2011. Incidental vs symptomatic renal tumours: Survival outcomes. Arab Journal of Urology 9(1): 17–21.
Luke C, Tracey E, Stapleton A and Roder D 2010. Exploring contrary trends in bladder cancer incidence, mortality and survival: implications for cancer research and cancer control. Internal Medicine Journal 40:357–62.
Qaseem A, Usman N, Jayaraj J S, et al. (September 02, 2019) Cancer of Unknown Primary: A Review on Clinical Guidelines in the Development and Targeted Management of Patients with the Unknown Primary Site. Cureus 11(9): e5552. doi:10.7759/cureus.5552
Smith D Supramaniam R, Marshall V and Armstrong B 2008. Prostate cancer and prostate specific antigen testing in New South Wales. Medical Journal of Australia 189(6): 315–18.
Vaccarella S, Franceschi S, Bray F, Wild C, Plummer M and Dal Maso L 2016. The increase in thyroid cancer may be due to an increase in medical surveillance and the introduction of new diagnostic techniques, such as neck ultrasonography. The New England Journal of Medicine 375: 614–17.
Victorian Cancer Registry 2023. Cancer in Victoria, 2022. Cancer Council Victoria, accessed 29 July 2024.
Wyld D, Wan M, Moore J, Dunn N and Youl P 2019. Epidemiological trends of neuroendocrine tumours over three decades in Queensland, Australia. Cancer Epidemiology, Volume 63, 101598, ISSN 1877–7821.